You are here

Article info

Article menu
Review
Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries

Authors

  1. Correspondence to Dr Mercy Mulaku, KEMRI-Wellcome Trust Research Programme, P.O. Box 43640, Nairobi 00100, Kenya; mmulaku{at}nairobi.kemri-wellcome.org
View Full Text

Citation

Mulaku M, Opiyo N, Karumbi J, et al
Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries
Archives of Disease in Childhood 2013;98:908-914.

Publication history

  • Received May 23, 2012
  • Revised April 2, 2013
  • Accepted August 8, 2013
  • First published August 30, 2013.
Online issue publication 
January 17, 2018

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/